2015 American Transplant Congress
Replacement of Lamivudine By Telbivudine to Improve Renal Function for Post-Transplant Hepatitis B Patients – A Randomized Clinical Trial
Background: Lamivudine is one of the anti-hepatitis B virus (HBV) agents to prevent HBV recurrence after transplantation because lamivudine is safe for long-term use. However,…2015 American Transplant Congress
Validation of the Model for End-Stage Liver Disease Score Criteria in Liver Transplantation for Acute Flare Up of Hepatitis B in Non-Cirrhotic Liver
Background: Decision of necessity of urgent liver transplantation for acute flare up of hepatitis B in the patients without cirrhosis is difficult. The MELD score…2015 American Transplant Congress
Comparison of Efficacy of Prophylactic Antivirus Therapies on Outcomes of Kidney Transplantation in Hepatitis B Virus Carriers
Purpose To compare the efficacy between entecavir and lamivudine as prophylactic antivirus therapy on long-term outcomes of HBV carriers after kidney transplantation.Methods We retrospectively reviewed…2015 American Transplant Congress
Active Immunization in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Preliminary Report of a Prospective Study
Aims: The aim of this study was to prospectively investigate the effectiveness and safety of procedural HBV vaccine in patients transplanted for hepatitis B virus…2015 American Transplant Congress
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss
Background: Co-infection with HIV and viral hepatitis results in poorer outcomes following liver transplantation. In this population, complex immune status, extensive drug regimens, and comorbid…2015 American Transplant Congress
Pretransplant Hepatitis B Viral Infection Increased Risk of Death After Kidney Transplantation
Clinical outcomes have not been well evaluated in kidney transplant recipients (KTRs) with hepatitis B virus (HBV). Here, we aimed to investigate the recent posttransplant…2015 American Transplant Congress
The Impact of Metabolic Syndrome and Prevalent Liver Disease on Living Donor Liver Transplantation: A Pressing Need to Expand the Pool
Background and Aims: Organ shortage has been the ongoing obstacle to expand liver transplantation world-wide. Living donor liver transplantation (LDLT) was hoped to improve this…2015 American Transplant Congress
Rituximab: Summarizing the Intracacies of the Black Box Warning and Expenses in Transplantation
Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY.
Post-transplant use of rituximab has become common, yet is associated with significant safety concerns and cost. Hepatitis B virus (HBV) reactivation following rituximab therapy poses…
- « Previous Page
- 1
- …
- 4
- 5
- 6